/5
0 avis
Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenografts
Archive ouverte
Edité par CCSD ; Ivyspring International Publisher -
Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenografts
Consulter en ligne
Chargement des enrichissements...